Pancreatic Cancer Progress: Expert Insights on Treatment Choices and Collaborating with Patients

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Pancreatic Cancer Progress: Enhancing Knowledge and Optimizing Innovations in Patient Care

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecological Malignancies: Safety and Adverse Event Management – Slides 

Content Format:

Slideset

Credit Type:

--

Credits:

--
HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecological Malignancies: Safety and Adverse Event Management

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.25
Evaluating Clinical Data With HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecologic Malignancies

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.25
Taking a New Path: Evaluating Clinical Data With HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecologic Malignancies – Slides

Content Format:

Slideset

Credit Type:

--

Credits:

--
HER2: Biology, Testing, and ADC-Based Treatment in Gastrointestinal, Genitourinary, and Gynecologic Malignancies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
HER2: Biology and Testing in Gastrointestinal, Genitourinary, and Gynecologic Malignancies

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.25
HER2: Biology and Testing in Gastrointestinal, Genitourinary, and Gynecologic Malignancies – Slides 

Content Format:

Slideset

Credit Type:

--

Credits:

--
Metastatic CRC: Personalizing Patient Care Using Current Evidence and Innovative Therapeutic Strategies

Content Format:

Slideset

Credit Type:

--

Credits:

--
Uncovering Safety and Signposts to the Future: AEs With HER2-Targeted ADCs and Future Applications

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.50
Taking a New Path: Evaluating Clinical Data With HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecological Malignancies

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.50
The Lay of the Land: Overview of Biology of HER2 in Genitourinary, Gastrointestinal, and Gynecologic Malignancies

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.25
Redefining the Possibilities for Patients With HER2-positive Gastroesophageal Cancers

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Redefining the Possibilities for Patients With HER2-Positive Gastroesophageal Cancers

Content Format:

Slideset

Credit Type:

--

Credits:

--
Emerging HER2-Targeted Antibody Drug Conjugates in Gastrointestinal Malignancies

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Think Tank on Emerging HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecologic Malignancies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
CCO Think Tank on Emerging HER2-Targeted ADCs: Gastrointestinal Malignancies

Content Format:

Slideset

Credit Type:

--

Credits:

--
Targeted Therapies for HER2-Positive Gastrointestinal Cancers: Experts Answer Your Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
HER2-Positive Advanced Gastrointestinal Cancers: Expert Guidance on Leveraging Targeted Agents to Improve Outcomes

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Incorporating Guideline-Recommended HER2 Testing Into GI Cancer Management

Content Format:

Slideset

Credit Type:

--

Credits:

--
Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Content Format:

Video

Credit Type:

AMA

Credits:

0.75
ExpressPoints: Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Content Format:

Slideset Download

Credit Type:

--

Credits:

--